
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and increasing demand for home healthcare solutions. Key players like Abbott and Medtronic are innovating with integrated continuous glucose monitoring systems. This expansion reflects a shift toward more accessible, cost-effective diabetes management worldwide.